Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product name | Phenformin |
CAS | 114-86-3 |
MF | C10H15N5 |
MW | 205.26 |
Melting point | 176.5 °C |
Boiling point | 333.94°C |
Phenformin hydrochloride increases the sensitivity of surrounding tissues to and increases mediated glucose utilization.
Phenformin hydrochloride increases the utilization of glucose by non--dependent tissues, such as brain, blood cells, renal medulla, intestines, skin, etc.
Phenformin hydrochloride inhibits liver gluconeogenesis and reduces liver glycogen output.
Phenformin hydrochloride inhibits glucose uptake by intestinal wall cells.
Phenformin hydrochloride inhibits the biosynthesis and storage of cholesterol, and reduces blood triglycerides and total cholesterol levels. Unlike, this product has no effect on promoting fat synthesis, and has no obvious blood sugar lowering effect on normal people. Generally, it does not cause hypoglycemia when used alone for type 2 diabetes.
Phenformin hydrochloride is a hydrochloride salt of phenformin from the biguanide drug class that displays anti-diabetic activity. It has been shown to increase AM.PK activity without increasing AMP/ATP activity. A particular study has shown that treating hearts with phenformin hydrochloride and then perfusing with Krebs-Henseleit buffer increased AMP and AM.PK activity and elevated phosphorylated acetyl-CoA carboxylase. Phenformin hydrochloride increases phosphorylation and AM.PK activity in the isolated heart, and this increase has always been correlated with and preceded by increased cytosolic .